ZEB2 and breast carcinoma: (G) Expression of ACSL4 and ZEB2 was analyzed by western blot in a panel of five breast cancer cell lines, including two basal-like (MAD-231, BT549), two luminal (T47D, MCF-7), and a Taxol-resistant cell lines.